FY26-27 Pediatric Covid-19 Vaccines
Awarded on June 1, 2026. Full description on SAM.gov.
Overview
- Posted
- June 3, 2026
- Notice type
- Award Notice
- Agency
- Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Notice details
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Place of performance
- Atlanta, Georgia, 30341
- Last updated
- Oct 29, 2026
- First published
- Last updated on SAM.gov
- Award date
- Jun 1, 2026
- Award amount (SAM.gov award notice)
- $285.0M
Identifiers
- Solicitation number
- 75D30126R73403
- Notice ID
- 214b852615ee4ebea66677f1f6d6adc4
- Award number (PIID)
- 75D30126D21000
Description
The Centers for Disease Control and Prevention (CDC) awards one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines.
Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program.
The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial market place. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds.
While the primary intention for the contracts is to procure vaccines for the 2026-2027 season, the government also has a requirement to be able to purchase vaccines for the 2025-2026 season, before vaccine becomes available for the 2026-2027 season.
Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Award Overview
Award Number
75D30126D21000
Award Amount (SAM.gov award notice)
$285.0M
Award Date
Jun 1, 2026
Awardee
Awardee Address
Princeton, NJ 08540, UNITED STATES
Original Solicitation
Notice ID: 214b852615ee4ebea66677f1f6d6adc4
Posted Date: Jun 3, 2026
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $84.8KSigned Nov 2, 2026
- $84.8KSigned Oct 30, 2026
- $6.0MSigned Oct 30, 2026
- $6.0MSigned Aug 28, 2026
- $6.0MSigned Aug 21, 2026
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Showing 6 of 6 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
Attachment 1 | Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | - | ||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 24.09 KB | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 22.16 KB | |||
Attachment 4 | Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | - | ||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 88.98 KB | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 572 KB |
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
FY26-27 Pediatric Covid-19 Vaccines
Other notices for this solicitation
- Combined SynopsisRelated noticeMar 4, 2026
FY26-27 Pediatric Covid-19 Vaccines
- Combined SynopsisRelated noticeMar 4, 2026
FY26-27 Pediatric Covid-19 Vaccines
- AwardedRelated noticeJun 3, 2026
FY26-27 Pediatric Covid-19 Vaccines
- AwardedRelated noticeJun 3, 2026
FY26-27 Pediatric Covid-19 Vaccines
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Adding the Q&A and additional information. The purpose of this amendment 01 is to provide a revise RFQ with a revised SOW. The National Institute for Occupational Safety and Health (NIOSH) operates basic science research facilities in Cincinnati, Ohio; Morgantown, West Virginia; Pittsburgh, Pennsylvania; and Spokane, Washington. Each location generates hazardous, universal, and other regulated waste through research and laboratory operations. Each location is considered a Small Quantity Generator of hazardous waste. The approximate average monthly quantities generated are: Location Approximate Monthly Quantity Cincinnati, Ohio 100 pounds Morgantown, West Virginia 500 pounds Pittsburgh, Pennsylvania 150 pounds Spokane, Washington 50 pounds Each location shall be treated as a separate job site. Hazardous waste shall be collected quarterly from designated collection areas. Contractor personnel shall not be required to enter individual laboratories. The acquisition is being pursued to obtain compliant collection, packaging, transportation, documentation, treatment, and final disposal services for waste generated at NIOSH facilities. The contractor shall provide complete cradle-to-final-disposal services and maintain the documentation necessary to demonstrate proper management of each waste stream. Performance shall comply with all applicable Federal, state, and local laws and regulations, including, as applicable, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, the Occupational Safety and Health Act, the Hazardous Materials Transportation Act, applicable United States Department of Transportation regulations in 49 CFR Parts 100–199, and applicable requirements in 40 CFR Parts 261 and 264/265. PURPOSE/OBJECTIVE The purpose of this acquisition is to obtain safe, lawful, and fully documented management of hazardous, universal, and other regulated waste generated at four NIOSH research facilities. The contractor shall provide all personnel, labor, supervision, transportation, packaging, equipment, supplies, supplies, permits, licenses, analysis, documentation, and other resources necessary to: Collect waste from designated collection areas; Package and label waste for shipment; Prepare and process required manifests and shipping documents; Transport waste in compliance with applicable requirements; Determine appropriate treatment or disposal methods; Ensure waste is delivered to properly permitted facilities; Complete final treatment or final disposal; and Provide documentation and audit trails demonstrating the ultimate disposition of each waste item. The contractor shall perform all work in a safe, prudent, conscientious, and professional manner. Work shall be performed during NIOSH normal working hours and shall comply with all applicable safety, environmental, transportation, and security requirements. SCOPE OF WORK The contractor shall provide quarterly removal of listed waste streams for the Cincinnati, Morgantown, Pittsburgh, and Spokane NIOSH locations. Each site shall be considered a separate job for scheduling, pickup, invoicing, documentation, and performance purposes. The contractor shall not be required to enter individual laboratories. All hazardous chemicals waste, universal waste, additional waste listed below, and gas cylinders are not associated with all four sites. Waste may include the following: Hazardous chemical waste Flammable liquids, including alcohol, xylene, acetonitrile, and ethyl acetate; Non-pouring flammables, including gas cylinders, solids, and metal powders; Inorganic and organic acids; Inorganic and organic bases; Oxidizers; Solid metals and metal powders; U-listed and P-listed wastes; Peroxides and reactive waste; Mercury compounds; Non-RCRA solids and liquids; Dioxin; Pentachlorophenol and polychlorinated biphenyl waste; Flammable aerosols; Formaldehyde, formaldehyde solutions, and glutaraldehyde-containing tissue specimens; Small quantities of explosives, generally from 1 to 1,000 grams; Paints; Sodium cacodylate; Potassium cacodylate; Waste oil; and Used or expired self-contained self-rescuer cartridges. Universal waste Batteries; Pesticides; Mercury-containing equipment; Lamps; and Aerosol cans. Additional waste Used oils; Charcoal filters; and Aqueous waste. Gas cylinders Toxic, corrosive, flammable, oxidizing, or refrigerant gas cylinders; Majority of cylinders are high pressure steel, 9-10”D X 48-51”H Some cylinders in Pittsburgh have unidentified contents. Gas-cylinder removal shall be provided as a separate line item. The estimated quantities are: Location Estimated Cylinders Cincinnati, Ohio 0 Morgantown, West Virginia 10 Pittsburgh, Pennsylvania 75 Spokane, Washington 15 Gas cylinders may be removed in one service event or over the life of the contract. Once removed, the cylinders are not expected to be replaced. The contractor shall provide lab-packs, drums, overpacks, packaging materials, labels, and other equipment necessary to safely consolidate, package, transport, and dispose of the waste. The contractor shall remain responsible for proper management of waste after it leaves NIOSH property, including transportation, spills, leaks, treatment, final disposal, and supporting documentation. TASKS TO BE PERFORMED Task 1: Provide Waste Collection and Packaging Services The contractor shall schedule and perform quarterly waste pickups at each NIOSH location. a. The contractor shall coordinate pickup dates with the designated NIOSH representative. b. The contractor shall collect waste from designated collection areas. c. The contractor shall not require access to individual laboratories. d. The contractor shall treat each NIOSH location as a separate job for scheduling and invoicing. The contractor shall provide all packaging and handling services required for safe shipment. a. The contractor shall supply lab-packs, drums, overpacks, labels, containers, absorbent materials, and other necessary packaging. b. The contractor shall package waste in accordance with applicable requirements. c. The contractor shall not require separation of tissue from formaldehyde solutions containing tissue. d. The contractor shall identify and manage incompatible waste streams appropriately. The contractor shall provide a separate line item for gas-cylinder removal. a. The contractor shall remove gas cylinders identified by NIOSH. b. The contractor shall manage cylinders with known or unidentified contents in accordance with applicable requirements. c. The contractor may remove cylinders during one service event or over the life of the contract. Task 2: Provide Transportation, Treatment, and Final Disposal Services The contractor shall transport waste in accordance with all applicable requirements. a. The contractor shall comply with United States Department of Transportation requirements in 49 CFR Parts 100–199. b. The contractor shall ensure that all approved subcontractors and transporters comply with applicable transportation requirements. c. The contractor shall ensure that shipping papers include required technical names, emergency-response information, and a 24-hour emergency telephone number. d. The contractor shall ensure that off-site shipments are properly labeled, marked, and placarded. The contractor shall provide final treatment and final disposal of all waste. a. The contractor shall send waste only to licensed, permitted, and approved facilities. b. The contractor shall ensure that each facility is authorized to handle the applicable waste streams and RCRA waste codes. c. Mere acceptance of waste at a treatment, storage, or disposal facility shall not constitute final treatment or final disposal. d. The contractor shall obtain documentation demonstrating completion of final treatment or final disposal. The contractor shall provide all required personnel, labor, equipment, permits, licenses, transportation, supplies, and services at no additional cost to the Government unless expressly authorized by the contract. Task 3: Prepare Manifests and Regulatory Documentation The contractor shall prepare a Hazardous Waste Manifest for each applicable shipment. a. The contractor shall use a paper, electronic, or approved hybrid manifest consistent with current EPA requirements. b. The contractor shall include manifest fees in the applicable invoice. c. The contractor shall comply with the hybrid-manifest process required for waste containing information that NIOSH determines should not be transmitted electronically. The contractor shall return the modified document to the NIOSH representative within 60 calendar days after pickup. The contractor shall provide certificates of disposal and supporting documentation. a. Documentation shall identify the treatment or disposal facility. b. Documentation shall identify the treatment or disposal method. c. Documentation shall demonstrate final treatment or final disposal. d. Documentation shall be submitted with, or before, the invoice for the applicable pickup. Task 4: Provide Safety, Spill Response, and Compliance Services The contractor shall perform all work in a safe and professional manner. a. Contractor personnel shall be trained and qualified to handle, package, and transport the waste assigned to them. b. Training shall address chemical incompatibility, basic first aid, spill response, and applicable regulatory requirements. c. The contractor shall provide appropriate personal protective equipment and handling equipment. d. NIOSH personnel may inspect contractor personnel and equipment while on NIOSH property. The contractor shall be responsible for spills or leaks caused by the contractor, its employees, agents, transporters, or subcontractors. a. The contractor shall immediately notify NIOSH of any spill or leak, regardless of quantity. b. The contractor shall perform required cleanup at no cost to NIOSH. c. The contractor shall submit a written report to NIOSH within 24 hours after the initial telephone notification. d. The report shall include the materials spilled, quantity, manifest number, reportability determination, notifications made, time and location, containment measures, communications with officials or the press, cleanup procedures, and final disposition of spill residue. The contractor shall obtain and maintain all licenses, permits, approvals, and authorizations necessary to perform the work. 4. The contractor shall comply with all applicable Federal, state, and local laws, regulations, codes, permits, and facility requirements. GOVERNMENT FURNISHED PROPERTY No Government-furnished property is identified at this time. The Government may provide the contractor with: Access to designated waste collection areas; Waste inventory information, if available; If there are any, Site-specific pickup instructions; Authorized NIOSH points of contact; and Information necessary to prepare manifests and support records. Any Government-furnished equipment, property, information system access, or other property shall be identified in the contract before issuance. PLACE OF PERFORMANCE AND CONTRACT SUPPORT HOURS Performance shall occur at the following NIOSH locations: Cincinnati, Ohio — Taft Building, 1150 Tusculum Ave. and Hamilton Building, 555 Ridge Ave.; Morgantown, West Virginia — 1095 Willowdale Road; Pittsburgh, Pennsylvania — 628 Cochran Mill Rd. Spokane, Washington — 315 E. Montgomery Ave. Waste treatment, storage, transportation, and final disposal may occur at contractor or subcontractor facilities that are properly licensed, permitted, and approved to handle the applicable waste streams. The contractor shall identify proposed transporters and treatment, storage, or disposal facilities when required by the solicitation or contract. The contractor shall ensure that all off-site facilities and transportation operations comply with applicable Federal, state, and local requirements. All on-site work shall be performed during NIOSH normal working hours: 8:00 a.m. through 5:00 p.m., of the facilities time zone. The contractor shall not perform on-site work during non-working hours unless specifically authorized in advance by the Contracting Officer. The contractor shall maintain a 24-hour emergency telephone number for reporting and responding to transportation emergencies, spills, leaks, or other incidents involving waste under the contractor’s control. | - | Solicitation | 11/17/2026 |
This BAA furthers NIOSH's statutory authority responsibilities for occupational mine safety and health research, including authority established under MINER Act of 2006 and in response to congressional direction supporting research on 1. Deep mining of critical minerals and metals, and 2. Air polluntant exposure risk in FY26. | - | Solicitation | 01/11/2027 |
The NIOSH OMSHR is seeking proposals from universities or colleges with ABET-accredited programs in mining engineering specifically focused on aspects of mining safety and health that addresses research, exploratory development, or testing of new innovations and technologies, and/or methods of evaluation of new and existing mining practices to improve mine health and/or safety. | - | Solicitation | 01/11/2027 |
The goal of this solicitation is to accelerate the development, adaptation, evaluation, demonstration, and adoption of innovative technologies that improve the safety and health of mine workers across coal, metal, nonmetal, stone, sand, and gravel mining operations. NIOSH seeks applied research and technology-development efforts that have a credible pathway toward practical implementation in surface or underground mines. Of particular interest are projects that: 1) Advance promising prototype technologies toward mine-ready solutions, including final development, adaptation to challenging mining environments, modification to meet applicable permissibility requirements, and demonstration at mine sites. 2) Adapt technologies successfully used in other industries for mining applications, including necessary redesign, ruggedization, integration, permissibility modifications, performance evaluation, and in-mine demonstration. 3) Evaluate emerging or candidate technologies to determine their potential to improve mine worker safety and health, identify technical or operational barriers to implementation, and develop approaches for overcoming those barriers. 4) Facilitate adoption of mature safety and health technologies that are available but have not achieved widespread mining-industry implementation. Activities may include establishing initial operational capability through mine demonstrations, evaluating technology performance and usability, identifying barriers to adoption, and determining modifications needed for practical industry acceptance. 5) Conduct analyses that identify emerging hazards and future technology needs, including analysis of safety, health, injury, fatality, exposure, surveillance, operational, or other relevant data to inform future research and technology-development priorities. | - | Solicitation | 02/08/2027 |
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | - | Market Research | 12/04/2026 |
Additional Details
Solicitation Number
75D30126R73403
Archive Date
Jun 16, 2026
Office Address
ATLANTA, GA, 30333